To determine the effect of CXCR4 blockade on T cell functionality during sepsis, we harvested splenocytes at 24 hours post-CLP from either untreated mice or mice treated with plerixafor as described above, and restimulated them with PMA/ionomycin for 4 hours in vitro to assess their ability to produce the effector cytokines IL-2, IFN-γ, and TNF. The gene discussed is CXCR4; the disease is Sepsis.